A few years ago, Pfizer (NYSE: PFE) saw revenue soar to record heights thanks to coronavirus-related sales, from its vaccine Comirnaty and its treatment Paxlovid. On top of this, the company's ...

As mentioned, Pfizer's major blockbusters have been on the decline, and that brings it to a major turning point. The company ...

Pfizer Inc. (NYSE:PFE) plays a significant role in global healthcare by supplying medicines and vaccines to healthcare ...

Pfizer PFE and AbbVie ABBV are leading U.S. drugmakers with strong positions across multiple therapeutic areas. Oncology ...

Pfizer has demonstrated remarkable financial resilience in its latest quarterly report, significantly outpacing Wall Street expectations across key metrics. The pharmaceutical powerhouse announced ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Value Stocks with Highest Dividends. On April 13, UBS Group AG raised its ...

Pfizer Inc. (NYSE:PFE) is one of the 8 Cheap Large Cap Stocks to Buy Now. On April 9, 2026, BofA lowered the price target on ...

Pfizer’s revenue soared to record heights a few years ago thanks to its coronavirus products, but growth has since slowed. The company is counting on new products, and a focus on oncology, to drive ...